PT Phapros Tbk (IDX:PEHA)

Market Cap	230.16B
Revenue (ttm)	806.40B
Net Income (ttm)	-46.65B
Shares Out	840.00M
EPS (ttm)	-55.54
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	129,600
Average Volume	36,140
Open	280.00
Previous Close	280.00
Day's Range	272.00 - 280.00
52-Week Range	260.00 - 525.00
Beta	0.45
RSI	42.84
Earnings Date	Apr 8, 2025

About PT Phapros Tbk

PT Phapros Tbk, together with its subsidiaries, operates in the pharmaceutical industry in Indonesia. The company operates through Ethical; Over the Counter (OTC) Drugs; Ethical; Generic Drugs Bearing; and Toll-in Manufacturing segments. It offers OTC drugs, including Antimo Anak, Livron B Plek, Noza, Hemorogard, Bioron, and others through pharmacies, retail, and drug stores. The company also provides generic drug products for government institutions and hospitals, as well as produces drugs for other pharmaceutical industries; and offers medica...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1954
• Employees: 1,474
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: PEHA

Financial Performance

In 2023, PT Phapros Tbk's revenue was 1.01 trillion, a decrease of -13.21% compared to the previous year's 1.17 trillion. Earnings were 5.96 billion, a decrease of -78.77%.